Skip to main content
PostersResources

Patient responses to weekly electronic patient reported outcomes using the Carevive PROmpt® platform

By October 12, 2021October 20th, 2021No Comments
Patient responses to weekly electronic patient reported outcomes using the Carevive PROmpt®platform

Authors: D’Ambra N. Dent, BA; Stacey A. Ingram, MEd; Valerie M. Lawhon, BS; Julie Scott RN, MSN; Nadia Still DNP, RN; Debra Wujcik, PhD, RN, FAAN; Carevive PROmpt®, Gabrielle B. Rocque, MD, MSPH; Smith Giri, MD,MHS Omer Jamy, MD

University of Alabama at Birmingham; Carevive Inc. 

Background

  • Home-based symptom monitoring using patient-reported outcomes has been shown to:
    • Reduce symptom burden and hospitalizations
    • Improve quality of life and overall survival

Objective

The primary goal of this study was to evaluate the early feasibility of home-based symptom monitoring.

Methods

Home-based symptom monitoring

  • Participants enrolled into Carevive PROmpt® symptom monitoring with the option to use of text, email, or both to complete weekly symptom surveys.
  • Patients receive an auto-generated self-management plans based on their electronic patient-reported outcomes (ePRO) responses.
  • Nurses respond to symptom alerts

 Study Design

  • Prospective single-arm pilot study evaluating feasibility of a two-part education and technology intervention (home-based symptom monitoring) for clinicians treating patients with Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML) patients

Participants

  • Patients aged 60 and older with MM or AML
  • Newly diagnosed or starting a new line of therapy and have not yet made a treatment decision

Data Collection

  • Patients received surveys between September 1, 2020 –May 19, 2021.
  • Chart abstraction in Carevive PROmpt® platform

Analysis

  • Descriptive statistics were calculated for the following outcomes:
    • Compliance rate
    • Completion rate
    • Survey alert type and frequency
  • Feasibility defined as compliance rate >70

Conclusion

This study demonstrated early feasibility with over 80% of patient completing their surveys with a high compliance rate.

Limitations

  • Findings may not apply to patients with other cancer types.
  • Findings were derived from a single institutions.

Future Directions

  • Future analysis will include screening and enrollment process, final implementation outcomes, and patient outcomes for all patients.

 

Patient responses to weekly electronic patient reported outcomes using the Carevive PROmpt®platform

Click to enlarge

Tags: